ZDHHC21 and acute myeloid leukemia: zDHHC21 depletion or inhibition prevented AK2 localization to the mitochondria and decreased OXPHOS and ATP production, inhibiting the growth and viability of AML cells and stem cells without impacting normal hematopoietic cells.